Pune, India

Rajeshkumar Maganlal Loriya

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Lupin, Inc., Lupin Atlantis Holdings Sa. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajeshkumar Maganlal Loriya. Retrieved from https://idiyas.com/inventor/rajeshkumar-maganlal-loriya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 9.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Pune, IN (2015 - 2018)
  • Maharashtra, IN (2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Rajeshkumar Maganlal Loriya in Pharmaceuticals

Introduction

Rajeshkumar Maganlal Loriya, based in Pune, India, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of four patents to his name, Loriya has focused on developing compounds that address critical medical issues, particularly in relation to voltage-gated sodium channels and calcium sensing receptors.

Latest Patents

Loriya's latest patents include remarkable innovations:

1. **Sulfonamide Compounds as Voltage-Gated Sodium Channel Modulators**

This invention relates to specific sulfonamide compounds designated by Formula (I) and their applications in treating diseases linked to the inhibition of Voltage-gated sodium channels (VGSC), particularly Na1.7. It details the pharmaceutically acceptable salts and compositions that can be utilized for medical purposes. Furthermore, the invention outlines a process for preparing these compounds, thus providing a valuable resource in the pharmaceutical industry.

2. **Substituted Chroman Compounds as Calcium Sensing Receptor Modulators**

This invention delivers a new class of calcium sensing receptor modulators (CaSR) aimed at managing and mitigating various health conditions associated with these receptors. The patent specifies methods and pharmaceutical compositions for treating diseases linked to CaSR modulation, along with a detailed process for synthesizing these innovative compounds.

Career Highlights

Throughout his career, Loriya has had the privilege of working with reputable companies in the pharmaceutical sector, including Lupin, Inc. and Lupin Atlantis Holdings S.A. His experience in these institutions has undoubtedly enriched his expertise and contributed to his ability to innovate within the field.

Collaborations

In addition to his work in various companies, Rajeshkumar has collaborated with notable colleagues such as Talha Hussain Khan and Venkata Poornapragnacharyulu Palle. These partnerships have fostered a collaborative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Rajeshkumar Maganlal Loriya stands as a prominent figure in the realm of pharmaceutical inventions. With his valuable patents and collaborative efforts, he continues to make strides in addressing significant medical challenges. His work not only showcases his expertise but also reflects the potential for further innovations in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…